Life ScienceCompany
Burixafor Ownership
Who owns Burixafor?
Burixafor is owned by GPCR Therapeutics. It was acquired on November 24, 2020.
Burixafor Business Overview
Where is Burixafor headquartered?
Burixafor is headquartered in South Korea.
What sector is Burixafor in?
Burixafor is a life science company.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.